Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Eicosapentaenoic acid

EU orphan designation number: EU/3/09/666   
Active ingredient: Eicosapentaenoic acid
Indication: Treatment of familial adenomatous polyposis
Sponsor: S.L.A. Pharma (UK) Limited
Elite House, Hill Farm Industrial Estate, Leavesden, Watford WD25 7SA, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Orphan designation EMEA/OD/040/09 (2009)7854 of 8/10/2009